Follow-up lung ultrasound to monitor lung failure in COVID-19 ICU patients.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
16
01
2022
accepted:
29
06
2022
entrez:
14
7
2022
pubmed:
15
7
2022
medline:
19
7
2022
Statut:
epublish
Résumé
Point-of-care lung ultrasound (LU) is an established tool in the first assessment of patients with coronavirus disease (COVID-19). To assess the progression or regression of respiratory failure in critically ill patients with COVID-19 on Intensive Care Unit (ICU) by using LU. We analyzed all patients admitted to Internal Intensive Care Unit, Ludwig-Maximilians-University (LMU) of Munich, from March 2020 to December 2020 suffering lung failure caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). LU was performed according to a standardized protocol at baseline and at follow up every other day for the first 15 days using a lung ultrasound score (LUSS). Ventilation data were collected simultaneously. Our study included 42 patients. At admission to ICU, 19 of them (45%) were mechanically ventilated. Of the non-invasive ventilated ones (n = 23, 55%), eleven patients required invasive ventilation over the course. While LUS did not differ at admission to ICU between the invasive ventilated ones (at baseline or during ICU stay) compared to the non-invasive ventilated ones (12±4 vs 11±2 points, p = 0.2497), LUS was significantly lower at d7 for those, who had no need for invasive ventilation over the course (13±5 vs 7±4 points, p = 0.0046). Median time of invasive ventilation counted 18 days; the 90-day mortality was 24% (n = 10) in our cohort. In case of increasing LUS between day 1 (d1) and day 7 (d7), 92% (n = 12/13) required invasive ventilation, while it was 57% (n = 10/17) in case of decreasing LUS. At d7 we found significant correlation between LU and FiO2 (Pearson 0.591; p = 0.033), p/F ratio (Pearson -0.723; p = 0.005), PEEP (Pearson 0.495; p = 0.043), pplat (Pearson 0.617; p = 0.008) and compliance (Pearson -0.572; p = 0.016). LUS can be a useful tool in monitoring of progression and regression of respiratory failure and in indicating intubation in patients with COVID-19 in the ICU.
Identifiants
pubmed: 35834575
doi: 10.1371/journal.pone.0271411
pii: PONE-D-22-00632
pmc: PMC9282475
doi:
Substances chimiques
RNA, Viral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0271411Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Respir Care. 2021 Aug;66(8):1263-1270
pubmed: 34006594
BMC Anesthesiol. 2021 Jun 28;21(1):178
pubmed: 34182946
Intensive Care Med. 2012 Apr;38(4):577-91
pubmed: 22392031
Emerg Med Australas. 2020 Aug;32(4):694-696
pubmed: 32386264
Radiology. 2020 Jun;295(3):E6
pubmed: 32167853
Acad Radiol. 2020 Oct;27(10):1363-1372
pubmed: 32713715
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Intensive Care Med. 2020 May;46(5):849-850
pubmed: 32166346
Ultrasound Med Biol. 2020 Nov;46(11):2908-2917
pubmed: 32807570
J Ultrasound Med. 2022 May;41(5):1077-1084
pubmed: 34291845
Am J Respir Crit Care Med. 2011 Feb 1;183(3):341-7
pubmed: 20851923
Intensive Care Med. 2020 Oct;46(10):1873-1883
pubmed: 32860069
Am J Emerg Med. 2021 Jul;45:290-296
pubmed: 33041130
PLoS One. 2021 Aug 25;16(8):e0256359
pubmed: 34432835
Am J Respir Crit Care Med. 2019 Mar 15;199(6):701-714
pubmed: 30372119
Crit Care Med. 2020 Dec;48(12):e1332-e1336
pubmed: 32932346
PLoS One. 2020 Jul 21;15(7):e0236312
pubmed: 32692769
Echocardiography. 2020 Apr;37(4):625-627
pubmed: 32239532
Nat Med. 2020 Jul;26(7):1017-1032
pubmed: 32651579
Am J Perinatol. 2021 May 27;:
pubmed: 34044459
Crit Care. 2020 Oct 6;24(1):596
pubmed: 33023638